Effect of celecoxib on experimental liver fibrosis in rat. (Q46899606)

26 December 2017

title

Effect of celecoxib on experimental liver fibrosis in rat. (English)

1 reference

26 December 2017

author name string

Alex Yui Hui

1

1 reference

26 December 2017

Wai Keung Leung

2

1 reference

26 December 2017

Henry Lik Yuen Chan

3

1 reference

26 December 2017

Francis Ka Leung Chan

4

1 reference

26 December 2017

Minnie Yin Yin Go

5

1 reference

26 December 2017

Ka Kui Chan

6

1 reference

26 December 2017

Bao Dong Tang

7

1 reference

26 December 2017

Eagle Siu Hong Chu

8

1 reference

26 December 2017

Joseph Jao Yiu Sung

9

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

published in

Liver International

1 reference

26 December 2017

volume

26

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

125-136

1 reference

26 December 2017

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Cytokine receptors and signaling in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Expression of connective tissue growth factor in experimental rat and human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Inhibition of the expression of alpha-smooth muscle actin in human hepatic stellate cell line, LI90, by a selective cyclooxygenase 2 inhibitor, NS-398.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Ethanol and arachidonic acid increase alpha 2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1. Role of H2O2 and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

A protective role for cyclooxygenase-2 in drug-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

A genetically clamped renin transgene for the induction of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

Coxibs and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01202.X

10.1111/J.1478-3231.2005.01202.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pnarc4f5avclbkphm5tbplnini

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_pnarc4f5avclbkphm5tbplnini

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pnarc4f5avclbkphm5tbplnini

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/pnarc4f5avclbkphm5tbplnini

1 reference